01 March 2024
01 March 2024
The US HHS Secretary called for state collaboration on a project to improve gene therapy access for sickle cell disease.
An Eli Lilly-sponsored GlobalData report finds that obese workers had $6,472 higher annual in medical and economic costs.
The new prefilled syringe formulation of XGEVA is intended for patients with bone metastases.
LUT014 is being investigated in an ongoing Phase II trial as a first-line treatment for EGFR inhibitor-induced acneiform rash, for which there is no approved drug.
Research has linked UPFs to various physical and mental health conditions.
The ALS pipeline comprises 109 candidates in various stages of development (Phase I–III) across the 8MM.
The latest financial injection increases the total capital raised by BlossomHill to $173m.
The infrastructure aims to facilitate and hasten the shift towards AI-driven drug discovery and development.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
